Literature DB >> 6825004

Surgical treatment of Wolff--Parkinson--White syndrome.

G M Guiraudon, G J Klein, D Jones, C R Kerr.   

Abstract

The Wolff--Parkinson--White syndrome may be associated with life-threatening or disabling tachyarrhythmia, owing to the presence of an atrioventricular accessory pathway (Kent bundle). The first division of a Kent bundle was reported in 1969, but this surgery is still confined to a few centres. Between September 1981 and October 1982, 19 patients (13 men, 6 women) aged 16 to 46 years (mean 25 years) with the Wolff--Parkinson--White syndrome associated with refractory arrhythmia underwent surgery. Kent bundles were localized in the electrophysiology laboratory and by intraoperative cardiac mapping. The 19 patients had a total of 22 distinct Kent bundles. The bundles were divided using open-heart (13 patients) or closed-heart (6 patients) technique. All Kent bundles were confirmed as nonfunctioning before discharge. A delta wave recurred in two patients. The Kent bundle was not functional in one patient. The other is controlled by a drug that was previously ineffective. There were no complications or deaths. Kent bundles can be divided with minimal morbidity and a high success rate (more than 90%). Surgery is indicated in patients with refractory arrhythmias or in young patients who would be required to take medication for life.

Entities:  

Mesh:

Year:  1983        PMID: 6825004

Source DB:  PubMed          Journal:  Can J Surg        ISSN: 0008-428X            Impact factor:   2.089


  2 in total

1.  Cryoablation of the accessory pathway in Wolff-Parkinson-White syndrome: initial results and long term follow up.

Authors:  E Rowland; K Robinson; S Edmondson; D M Krikler; H H Bentall
Journal:  Br Heart J       Date:  1988-04

2.  Alfentanil-midazolam anaesthesia has no electrophysiological effects upon the normal conduction system or accessory pathways in patients with Wolff-Parkinson-White syndrome.

Authors:  M D Sharpe; W B Dobkowski; J M Murkin; G Klein; G Guiraudon; R Yee
Journal:  Can J Anaesth       Date:  1992-10       Impact factor: 5.063

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.